Found 11 matching trials
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
NARosiglitazone (RSG) has been tested in clinical studies and is approved by ...
Location
GSK Investigational Site
QTc Study of Rosi XR in Healthy Volunteers
PHASE1This study is a randomised double blind, parallel group, and will evaluate ...
Location
GSK Investigational Site
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
PHASE2Clinical features in patients with the familial early onset forms and the s...
Location
GSK Investigational Site
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
PHASE3Rosiglitazone (RSG) has been tested and is approved as a treatment for type...
Location
GSK Investigational Site
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
PHASE3This is a Phase III, multicenter, open-label extension, single-group study ...
Location
GSK Investigational Site
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
PHASE2This is a placebo-controlled study evaluating the effects of rosiglitazone ...
Location
GSK Investigational Site
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
PHASE3This is a Phase III, multicenter, open-label extension, single-group study ...
Location
GSK Investigational Site
PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers
PHASE1The present pharmacokinetic study is designed to further characterise the p...
Location
GSK Investigational Site
Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
PHASE2This is an open-label extension to study 49653/461, to assess the long-term...
Location
GSK Investigational Site
Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)
PHASE1The present pharmacokinetic study is designed to assess the pharmacokinetic...
Location
GSK Investigational Site